Viewing Study NCT02870920


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-03-08 @ 4:12 AM
Study NCT ID: NCT02870920
Status: COMPLETED
Last Update Posted: 2023-12-08
First Post: 2016-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer
Sponsor: Canadian Cancer Trials Group
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-10-12
Start Date Type: ACTUAL
Primary Completion Date: 2018-10-18
Primary Completion Date Type: ACTUAL
Completion Date: 2022-06-07
Completion Date Type: ACTUAL
First Submit Date: 2016-08-10
First Submit QC Date: None
Study First Post Date: 2016-08-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-11-20
Results First Submit QC Date: None
Results First Post Date: 2021-01-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-12-06
Last Update Post Date: 2023-12-08
Last Update Post Date Type: ACTUAL